secwatch / observer
8-K filed May 6, 2026, 7:59 PM ET ticker LSAK CIK 0001041514
earnings confidence high sentiment positive materiality 0.75

Lesaka Q3 adj EPS $0.11, net rev up 16%, raises FY2026 EPS guidance

LESAKA TECHNOLOGIES INC

2026-Q3 EPS reported -$0.01 revenue$533,233,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LESAKA TECHNOLOGIES INC reported Full Fiscal Year 2026 ending June 30, 2026 results: revenue between ZAR 6.2 billion and ZAR 6.5 billion, net income Net Income Attributable to Lesaka to be positive, EPS between ZAR 5.50 and ZAR 6.00. Guidance raised.

Period
Full Fiscal Year 2026 ending June 30, 2026
Revenue
between ZAR 6.2 billion and ZAR 6.5 billion
Net income
Net Income Attributable to Lesaka to be positive
EPS
between ZAR 5.50 and ZAR 6.00
Guidance
raised
Result
guidance update
Exact text from the filing
For FY2026, the year ending June 30, 2026, we expect: Net Revenue between ZAR 6.2 billion and ZAR 6.5 billion. Group Adjusted EBITDA between ZAR 1.25 billion and ZAR 1.35 billion. Net Income Attributable to Lesaka to be positive. Adjusted earnings per share between ZAR 5.50 and ZAR 6.00.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

LESAKA TECHNOLOGIES INC updated its the third quarter of fiscal 2026 ended March 31, 2026 guidance (raised).

Period
the third quarter of fiscal 2026 ended March 31, 2026
Guidance
raised
Result
reported results
Exact text from the filing
On May 6, 2026, Lesaka Technologies, Inc., a Florida corporation (the " Company "), issued a press release setting forth its financial results for the third quarter ended March 31, 2026.
View on SEC.gov

Browse all earnings releases →

LESAKA TECHNOLOGIES INC filing history →

Source: SEC EDGAR
accession 0001062993-26-002361
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.